Scientists are probing woolly mammoth and Neanderthal genetic codes for new compounds as today’s drugs lose potency.

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...

Nabriva, an antibiotic biotech, recently announced that they were winding down its operations. While this is sad, it may not be so much a market failure problem in this particular case. Last week, a ...

U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...

Today, antibiotics are the third largest-selling ... manufactured by Micrologix Biotech (Vancouver, BC). The two-part phase II trials are intended to assess the safety, pharmacokinetics, and ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

In 2025, the global proteose peptone market is anticipated to be worth USD 151.4 million, with projections indicating a rise ...

RGCB have discovered innovative methods to tackle bacterial resistance to antibiotics, a growing global health threat. Their approach targets porins in bacterial outer membranes. This collaborative ...

India has launched the first indigenous antibiotic for drug-resistant infections. Known as 'Nafithromycin,' the drug has been ...

While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

Repeated perinatal antibiotic exposure in very low-birth-weight preterm infants was associated with impaired lung function ...